Colorectal and pancreatic cancer rates up 10% in last 30 years, major study reveals

by Spink HealthCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The results of a major study across 195 countries, presented today at UEG Week Barcelona 2019, indicate

Updated on: May 21,2024

Colorectal and pancreatic cancer rates up 10% in last 30 years, major study reveals

by Spink HealthCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The results of a major study across 195 countries, presented today at UEG Week Barcelona 2019, indicate

Updated on:May 21,2024

Researchers suggest rethinking 'cancer' label for early-stage prostate changes

byOxford University PressCredit: CC0 Public DomainA new paper in theJournal of the National Cancer Instituteindicates that patients may benefit if doctors stop calling certain early-

Updated on: November 10,2024

Researchers suggest rethinking 'cancer' label for early-stage prostate changes

byOxford University PressCredit: CC0 Public DomainA new paper in theJournal of the National Cancer Instituteindicates that patients may benefit if doctors stop calling certain early-

Updated on:November 10,2024

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar

Updated on: April 01,2024

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar

Updated on:April 01,2024

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be

Updated on: January 23,2024

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be

Updated on:January 23,2024

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on: November 11,2024

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on:November 11,2024

On a stretch of gravel road, families ravaged by cancer question nitrate

by Jennifer Bjorhus, Star TribuneCredit: Unsplash/CC0 Public DomainCancer ravaged Brian Bennerotte's body and those of many around him—his father, five brothers and his sister—as well as others al

Updated on: April 20,2024

On a stretch of gravel road, families ravaged by cancer question nitrate

by Jennifer Bjorhus, Star TribuneCredit: Unsplash/CC0 Public DomainCancer ravaged Brian Bennerotte's body and those of many around him—his father, five brothers and his sister—as well as others al

Updated on:April 20,2024

Novel anti-cancer nanomedicine for efficient chemotherapy

by University of HelsinkiThe new exosome-based nanomedicines enhanced tumor accumulation, extravasation from blood vessels and penetration into deep tumor parenchyma after intravenous administrat

Updated on: May 09,2024

Novel anti-cancer nanomedicine for efficient chemotherapy

by University of HelsinkiThe new exosome-based nanomedicines enhanced tumor accumulation, extravasation from blood vessels and penetration into deep tumor parenchyma after intravenous administrat

Updated on:May 09,2024

Researchers publish preclinical data on new drug combination to treat neuroblastoma

by Texas Tech UniversityTTUHSC's C. Patrick Reynolds, M.D., Ph.D., recently published preclinical data on a new drug combination to treat neuroblastoma. Credit: TTUHSCNeuroblastoma is the mos

Updated on: June 15,2024

Researchers publish preclinical data on new drug combination to treat neuroblastoma

by Texas Tech UniversityTTUHSC's C. Patrick Reynolds, M.D., Ph.D., recently published preclinical data on a new drug combination to treat neuroblastoma. Credit: TTUHSCNeuroblastoma is the mos

Updated on:June 15,2024

Tumor matrix profiling gives clues to progression of some lung cancers

byGarvan Institute of Medical ResearchGraphic of lungs and cells. Credit: Thomas Cox/Garvan InstituteScientists at the Garvan Institute of Medical Research have identified molecular profiles of

Updated on: January 22,2024

Tumor matrix profiling gives clues to progression of some lung cancers

byGarvan Institute of Medical ResearchGraphic of lungs and cells. Credit: Thomas Cox/Garvan InstituteScientists at the Garvan Institute of Medical Research have identified molecular profiles of

Updated on:January 22,2024

Researchers unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues

byInstitute for Research in Biomedicine (IRB Barcelona)The origin of second solid tumors of cases 3 (A–D) and 4 (E–F). A, Eight years after the development of NB, the child presented with MRT. B

Updated on: March 30,2024

Researchers unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues

byInstitute for Research in Biomedicine (IRB Barcelona)The origin of second solid tumors of cases 3 (A–D) and 4 (E–F). A, Eight years after the development of NB, the child presented with MRT. B

Updated on:March 30,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on: March 01,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on:March 01,2024

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre

Updated on: May 11,2024

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre

Updated on:May 11,2024